ITUB20160857A1 - Una forma di dosaggio comprendente solfato di calcio, collagene e un farmaco e relativo uso in un metodo di rilascio modificato avente un meccanismo di regolazione insito nella sua composizione. - Google Patents

Una forma di dosaggio comprendente solfato di calcio, collagene e un farmaco e relativo uso in un metodo di rilascio modificato avente un meccanismo di regolazione insito nella sua composizione.

Info

Publication number
ITUB20160857A1
ITUB20160857A1 ITUB2016A000857A ITUB20160857A ITUB20160857A1 IT UB20160857 A1 ITUB20160857 A1 IT UB20160857A1 IT UB2016A000857 A ITUB2016A000857 A IT UB2016A000857A IT UB20160857 A ITUB20160857 A IT UB20160857A IT UB20160857 A1 ITUB20160857 A1 IT UB20160857A1
Authority
IT
Italy
Prior art keywords
collagen
drug
composition
dosage form
calcium sulfate
Prior art date
Application number
ITUB2016A000857A
Other languages
English (en)
Inventor
Bruno Silvestrini
Original Assignee
Bruno Silvestrini
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bruno Silvestrini filed Critical Bruno Silvestrini
Priority to ITUB2016A000857A priority Critical patent/ITUB20160857A1/it
Priority to EP17719930.4A priority patent/EP3416625A1/en
Priority to PCT/IT2017/000029 priority patent/WO2017141282A1/en
Publication of ITUB20160857A1 publication Critical patent/ITUB20160857A1/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2063—Proteins, e.g. gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1658—Proteins, e.g. albumin, gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ITUB2016A000857A 2016-02-18 2016-02-18 Una forma di dosaggio comprendente solfato di calcio, collagene e un farmaco e relativo uso in un metodo di rilascio modificato avente un meccanismo di regolazione insito nella sua composizione. ITUB20160857A1 (it)

Priority Applications (3)

Application Number Priority Date Filing Date Title
ITUB2016A000857A ITUB20160857A1 (it) 2016-02-18 2016-02-18 Una forma di dosaggio comprendente solfato di calcio, collagene e un farmaco e relativo uso in un metodo di rilascio modificato avente un meccanismo di regolazione insito nella sua composizione.
EP17719930.4A EP3416625A1 (en) 2016-02-18 2017-02-16 A dosage form comprising a calcium salt, collagen and a drug and related use in a method of controlled release endowed with a regulatory mechanism of drug release inside the composition
PCT/IT2017/000029 WO2017141282A1 (en) 2016-02-18 2017-02-16 A dosage form comprising a calcium salt, collagen and a drug and related use in a method of controlled release endowed with a regulatory mechanism of drug release inside the composition

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITUB2016A000857A ITUB20160857A1 (it) 2016-02-18 2016-02-18 Una forma di dosaggio comprendente solfato di calcio, collagene e un farmaco e relativo uso in un metodo di rilascio modificato avente un meccanismo di regolazione insito nella sua composizione.

Publications (1)

Publication Number Publication Date
ITUB20160857A1 true ITUB20160857A1 (it) 2017-08-18

Family

ID=56134463

Family Applications (1)

Application Number Title Priority Date Filing Date
ITUB2016A000857A ITUB20160857A1 (it) 2016-02-18 2016-02-18 Una forma di dosaggio comprendente solfato di calcio, collagene e un farmaco e relativo uso in un metodo di rilascio modificato avente un meccanismo di regolazione insito nella sua composizione.

Country Status (3)

Country Link
EP (1) EP3416625A1 (it)
IT (1) ITUB20160857A1 (it)
WO (1) WO2017141282A1 (it)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT201700093635A1 (it) * 2017-08-14 2019-02-14 Bruno Silvestrini Una forma di dosaggio topica comprendente un sale di calcio, collagene e un farmaco e relativo uso in un metodo di rilascio modificato avente un meccanismo di regolazione insito nella sua composizione.

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3507952A (en) * 1968-12-20 1970-04-21 Smithkline Corp Sustained release bolus for animal husbandry
US4163777A (en) * 1977-04-29 1979-08-07 Lewis/Howe Company Controlled antacid delivery form and method of treatment therewith
US4717713A (en) * 1983-10-31 1988-01-05 Research Corporation Controlled release liquid pharmaceutical
US5425769A (en) * 1990-04-23 1995-06-20 Snyders, Jr.; Robert V. Composition of material for osseous repair
WO2016068228A1 (ja) * 2014-10-29 2016-05-06 株式会社高研 薬剤徐放担体及び薬剤徐放方法

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3507952A (en) * 1968-12-20 1970-04-21 Smithkline Corp Sustained release bolus for animal husbandry
US4163777A (en) * 1977-04-29 1979-08-07 Lewis/Howe Company Controlled antacid delivery form and method of treatment therewith
US4717713A (en) * 1983-10-31 1988-01-05 Research Corporation Controlled release liquid pharmaceutical
US5425769A (en) * 1990-04-23 1995-06-20 Snyders, Jr.; Robert V. Composition of material for osseous repair
WO2016068228A1 (ja) * 2014-10-29 2016-05-06 株式会社高研 薬剤徐放担体及び薬剤徐放方法

Also Published As

Publication number Publication date
WO2017141282A1 (en) 2017-08-24
EP3416625A1 (en) 2018-12-26

Similar Documents

Publication Publication Date Title
IL279015A (en) Anti-interleukin-17A antibody, its pharmaceutical preparation and its use
BR112015031475A2 (pt) composto, composição farmacêutica, método para tratamento de uma doença ou condição, kit, e, uso de composto.
BR112018005750A2 (pt) composições para higiene bucal.
CL2008000510A1 (es) Compuestos conjugados farmaco-ligandos, que se unen a citotoxinas potentes; composicion farmaceutica; y uso para retardar o detener el crecimiento de un tumor en un mamifero.
CL2014000131A1 (es) Procedimiento para la fabricacion de una composicion farmaceutica en forma de tabletas de liberacion prolongada que comprende pirfenidona; y su uso para el tratamiento o regresion de la insuficiencia renal cronica, contractura capsular mamaria y fibrosis hepatica.
IL275478A (en) A preparation that functions as a bromodomain protein inhibitor, and the composition
EP3610874A4 (en) PHARMACEUTICAL COMPOSITION CONTAINING A MOR AGONIST AND A KOR AGONIST, AND ITS USES
BR112016014595A2 (pt) material à base de sólido para uso tópico sobre a pele,composição aquosa e método de produção do mesmo.
EP3285765A4 (en) A composition comprising a photosensitive compound in a polymeric nanoparticle, and a method of using the composition
BR112015031979A2 (pt) letermovir, formulação farmacêutica oral sólida, uso de uma formulação farmacêutica oral sólida, e processo para preparar letermovir.
CO2019003162A2 (es) Formas cristalinas y salinas de compuestos agonistas de ppar
RS64337B1 (sr) Farmaceutska formulacija koja sadrži antitelo, ciklodekstrin i metionin
BR112019023123A2 (pt) Artigo pultrudado, uso do artigo pultrudado, método para formar o artigo
EP3306361A4 (en) REFLECTIVE LIGHT-EMITTING FILM, MANUFACTURING METHOD AND USE THEREOF
EP3680330A4 (en) STABILIZED DRY PROTEIN EMIDASE COMPOSITION
SG11202101435XA (en) ANTIBODY AGAINST IL-1ß, PHARMACEUTICAL COMPOSITION AND USE THEREOF
BR112018005299A2 (pt) 1,1-difeniletilenos substituídos com alquenilfenoxi, processos para sua preparação e seu uso
EP3476864A4 (en) ANTIBODIES AGAINST ETAR, PHARMACEUTICAL COMPOSITION AND USE THEREOF
ITUB20160857A1 (it) Una forma di dosaggio comprendente solfato di calcio, collagene e un farmaco e relativo uso in un metodo di rilascio modificato avente un meccanismo di regolazione insito nella sua composizione.
ITUB20153248A1 (it) Polvere di polietilene, procedimento per la sua preparazione e suo utilizzo per stampaggio rotazionale
IT201700093635A1 (it) Una forma di dosaggio topica comprendente un sale di calcio, collagene e un farmaco e relativo uso in un metodo di rilascio modificato avente un meccanismo di regolazione insito nella sua composizione.
ITUB20152471A1 (it) Composizione cosmetica in forma di polvere compatta, suo procedimento di preparazione e relativi usi.
EP3483181A4 (en) BLYS ANTIBODIES, PRODUCTION METHOD THEREFOR AND APPLICATION THEREOF
BR112018001719A2 (pt) composição farmacêutica com micela polimérica, e, método para preparação de uma composição farmacêutica com micela polimérica.
IL284098A (en) A preparation for soothing the skin in the form of an emulsion